It is clear that biofilms represent an important challenge in the treatment of infectious diseases. Biofilm are involved in more than 60% of infections, typically associated with chronic, recurring and device-related infections.
NEXT-GENERATION ANTIMICROBIALS
It is clear that
biofilms represent an important challenge in the treatment of infectious
diseases. Biofilm are involved in more than 60% of infections, typically associated
with chronic, recurring and device-related infections. Furthermore, we now know
that that existing antimicrobials have been selected for efficacy against
planktonic organisms and are often much less effective against biofilms. What
is clearly needed is a paradigm shift for the selection and development of
antimicrobials, which will ensure efficacy against biofilms.
Related Topics
TH 2019 - 2024 pharmacy180.com; Developed by Therithal info.